From: Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study
Clinical characteristic | KT group (n = 12,634) | Control group (n = 12,634) | P |
---|---|---|---|
Age (years) |  |  |  < 0.001 |
Under 20 | 0 (0.0) | 6 (0.1) | Â |
20–34 | 790 (6.3) | 5818 (46.1) |  |
35–49 | 5145 (40.7) | 3931 (31.1) |  |
50–64 | 6040 (47.8) | 1812 (14.3) |  |
65 or over | 659 (5.2) | 1067 (8.4) | Â |
Sex |  |  |  < 0.001 |
Male | 8310 (65.8) | 6073 (48.1) | Â |
Female | 4324 (34.2) | 6561 (51.9) | Â |
Insurance type |  |  |  < 0.001 |
Social health insurance | 10,781 (85.3) | 12,134 (96.0) | Â |
Medical aid | 1852 (14.7) | 495 (3.9) | Â |
Veterans | 1 (0.0) | 5 (0.1) | Â |
Person with comorbidities | 5816 (46.0) | 803 (6.4) |  < 0.001 |
Type of comorbidities | |||
Diabetes mellitus | 4009 (31.7) | 313 (2.5) |  < 0.001 |
Ischemic heart disease | 1869 (14.8) | 202 (1.6) |  < 0.001 |
Heart failure | 1241 (9.8) | 65 (0.5) |  < 0.001 |
Liver cirrhosis | 1083 (8.6) | 341 (2.7) |  < 0.001 |
Chronic obstructive pulmonary disease | 234 (1.9) | 55 (0.4) |  < 0.001 |